Hyoscyamine + Methenamine + Methylene Blue + Phenyl Salicylate + Sodium Phosphate, Monobasic,
Fixed-dose combination
This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.
Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.
Active ingredients
- Hyoscyamine
hyoscyamine - Methenamine
methenamine - Methylene Blue
methylene-blue - Phenyl Salicylate
phenyl-salicylate - Sodium Phosphate, Monobasic,
sodium-phosphate-monobasic
Brands with this exact combination
| Brand | Dose | Manufacturer |
|---|---|---|
| methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfateUS | 120 mg / 40.8 mg / 36.2 mg / 10.8 mg / 0.12 mg | Allegis Pharmaceuticals, LLC |
| URELLEUS | 0.12 mg / 81 mg / 10.8 mg / 32.4 mg / 40.8 mg | Viatris Specialty LLC |
| hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, and sodium phosphate, monobasic, monohydrateUS | 0.12 mg / 81 mg / 10.8 mg / 32.4 mg / 40.8 mg | Viatris Specialty LLC |
| URIMAR-T CAPSUS | 120 mg / 40.8 mg / 36.2 mg / 10.8 mg / 0.12 mg | Allegis Pharmaceuticals, LLC |
| Uretron D/SUS | 40.8 mg / 36.2 mg / 0.12 mg / 10.8 mg / 81.6 mg | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals |
| Methenamine, Sodium Phosphate Monobasic, Phenyl Salicylate, Methylene Blue, and Hyoscyamine SulfateUS | 40.8 mg / 36.2 mg / 0.12 mg / 10.8 mg / 81.6 mg | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals |
| MB CAPSUS | 120 mg / 40.8 mg / 36.2 mg / 10.8 mg / 0.12 mg | Allegis Pharmaceuticals, LLC |
| Uro-MPUS | 118 mg / 40.8 mg / 36 mg / 10 mg / 0.12 mg | Method Pharmaceuticals, LLC |
| Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine SulfateUS | 118 mg / 40.8 mg / 36 mg / 10 mg / 0.12 mg | Method Pharmaceuticals, LLC |
Same combination in other markets
No product with this combination is recorded in the other covered markets yet.
See warnings for these ingredients
Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.